Oxfordshire-UK, Singapore – September 1st 2022 Phynova Group Ltd announces a new strategic partnership with Singapore-based Nutraconnect Pte, Ltd. to introduce its innovative, scientifically backed nutraceutical ingredient Reducose® to critical markets in Asia namely Indonesia & Thailand. This strategic partnership will also aim to take Reducose to certain Key marquee brands in the APAC region.Read more
Nestlé have published results from a clinical trial evaluating the effect of Reducose® on glucose response following a complete meal. In the study, 30 healthy individuals consumed either 250mg of Reducose® prior to a meal or 250mg Reducose® mixed directly into the meal, with blood glucose measurements recorded every 10 minutes using an Abbott FreestyleRead more
Oxford (UK) and Sydney (AU), June 2022 Phynova Group Ltd and Ingredients Plus announce a distribution partnership for Reducose®, for use in Supplement applications to customers in Oceania. Reducose® is Phynova’s patented and clinically researched White Mulberry leaf extract that supports significant lowering of post-meal blood sugar and insulin response as well as enabling foodRead more
Oxford, Moscow, January 2022 PHYNOVA Group Ltd (“Phynova”) and INVITA-Trade (“InVita”) announce an exclusive distribution agreement for Reducose®, for use in Food and Supplement applications to customers in Russia, Kazakhstan, Belarus, and Armenia. Reducose® is Phynova’s patented and clinically researched White Mulberry leaf extract that supports significant lowering of post-meal blood sugar and insulin responseRead more
